Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

German Patient Surpasses 5 Years of Support on DuraHeartâ„¢ Left Ventricular Assist Device

July 19, 2011 3:40 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., July 19, 2011 /- Terumo Heart, Inc., a wholly owned subsidiary of Terumo Corporation, today announced that a patient implanted with the DuraHeart™ Left Ventricular Assist System (LVAS) has surpassed five years of support on the mechanical circulatory support...

FDA Approves Vaccines for the 2011-2012 Influenza Season

July 18, 2011 10:47 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce and distribute influenza...

HASCO Medical Announces New Redesigned Websites for Mobility Freedom and Wheelchair Vans of America

July 18, 2011 4:38 am | by Bio-Medicine.Org | News | Comments

MOBILE, Ala., July 18, 2011 /- HASCO Medical, Inc. (OTCBB: HASC), www.mysouthernmed.com , a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced the launch of a newly redesigned  web site for Mobility Freedom ( www.MobilityFreedom.com ) and...

Advertisement

Dehaier Opens First Oxygen Filling Facility and First Service Center for Home Oxygen Therapy Service in Beijing

July 18, 2011 4:38 am | by Bio-Medicine.Org | News | Comments

BEIJING, July 18, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced the opening of...

MSA Schedules Second Quarter Earnings Webcast

July 14, 2011 11:37 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, July 14, 2011 /- MSA (NYSE: MSA ), the global leader in the development, manufacture and supply of products that protect people's health and safety, announced today that it will broadcast a second quarter 2011 earnings conference call live via the Internet on Thursday, July...

Cancer Mortality Rates are Higher in Men than Women

July 14, 2011 8:34 am | by AACR | News | Comments

Tweet • Disparity driven by gender differences in cancer incidence. • Cancer survival largely similar between men and women. • Research needed to understand gender disparities in cancer incidence. PHILADELPHIA - Overall cancer mortality rates are higher for men than women in the United...

Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox

July 13, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

STEVENSVILLE, Md., July 13, 2011 /PRNewswire-USNewswire/ -- Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has received approval from the Medical Device Bureau of Health Canada for the Precision Flow® Heliox...

Kimberly-Clark Launches KimVent Multi-Access Port Closed Suction System

July 13, 2011 10:33 am | by Bio-Medicine.Org | News | Comments

ROSWELL, Ga., July 13, 2011 /- Marking a significant advance in the fight against Ventilator-associated Pneumonia (VAP), Kimberly-Clark Health Care today announced its launch of KimVent Multi-Access Port (MAP) Closed Suction Systems. The new system features a compact rotating manifold...

Advertisement

Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer

July 13, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, July 13, 2011 /- Eli Lilly and Company (NYSE: LLY ) announced that it has made a charitable contribution to the Patient Advocate Foundation (PAF). The donation will enable expansion of the foundation's patient services programs, including Case Management and Co-Pay Relief...

MetroSouth Surgeon Pioneers Hybrid Treatment of Large Hiatal Hernias and Reflux

July 13, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

BLUE ISLAND, Ill., July 13, 2011 /- Chronic reflux patients who also suffer from large hiatal hernias can now get relief in just one visit to the operating room. MetroSouth Medical Center general surgeon Felipe Gracias, MD, Palos Park, is the first physician in Illinois to treat both...

Kessler is the First Rehabilitation Center in the Nation to Use New Robotic Gait Training System

July 13, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

WEST ORANGE, N.J., July 13, 2011 /- Kessler Foundation ( www.kesslerfoundation.org ) and Kessler Institute for Rehabilitation ( www.kessler-rehab.com ) are the first rehabilitation centers in the U.S. to implement the new LokomatPro V6, an advanced robotic training system designed to...

HASCO Medical Inc. Names Mike Dumais the Vice President of Sales for Southern Medical and Mobility

July 11, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

MOBILE, Ala., July 11, 2011 /- HASCO Medical, Inc. (OTCBB: HASC), www.mysouthernmed.com , a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today that Mike Dumais has been named Vice President of Sales for Southern Medical and Mobility, a...

GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older

July 8, 2011 9:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, July 8, 2011 /- The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 65 years of age and older for active booster immunization against tetanus,...

Advertisement

FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People

July 8, 2011 5:35 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 8, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Boostrix vaccine to prevent tetanus, diphtheria, and pertussis (whooping cough) in people ages 65 and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO )...

Significant Rise in Survival Rates for Elderly Lung Cancer Patients Treated Using Radiosurgery in Netherlands Detailed at World Conference for Lung Cancer

July 6, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

AMSTERDAM, July 6, 2011 /- Details of advances in the use of stereotactic body radiotherapy (SBRT) to treat early stage lung cancer in both high risk operable and inoperable cases were presented at the biennial World Conference for Lung Cancer (WCLC) here in Amsterdam today, including...

ResMed Announces Acquisition of BiancaMed

July 6, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, July 6, 2011 /- ResMed Inc. (NYSE: RMD and ASX: RMD), a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders, announced today that it has acquired BiancaMed Ltd., a...

First Reportable Data of EarlyCDTâ„¢-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer

July 5, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

AMSTERDAM, July 5, 2011 /- Oncimmune ® LLC, maker of EarlyCDT™-Lung , a simple blood test that aids physicians in the risk assessment and early detection of lung cancer , today announces that an abstract (P4.013) " EarlyCDT-Lung test: audit of 1,000 patients in clinical...

VisionGate to Present at IASLC Meeting Showing How Adjunctive Use of Its 3D Cell Imaging Platform Can Increase Utility of CT Screening for Lung Cancer

July 3, 2011 10:32 pm | by Bio-Medicine.Org | News | Comments

AMSTERDAM and PHOENIX, July 4, 2011 /- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED™ test can improve the utility of low dose x-ray...

FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery

July 1, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J., July 1, 2011 /- Janssen Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved XARELTO® (rivaroxaban tablets), a novel, once-daily, oral anticoagulant for the prevention (prophylaxis) of deep vein thrombosis (DVT) which may...

Fast Track Total Hip Replacement Surgery Is Effective and Safe

July 1, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 1, 2011 /- Generally healthy patients who undergo total hip replacement (THR) can be fast tracked to be discharged in two days compared with the standard three to six days, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City. The...

Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal

July 1, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SOUTH PLAINFIELD, N.J., July 1, 2011 /- PTC Therapeutics, Inc. (PTC) today announced the publication of data from a Phase 2 study of ataluren, an investigational new drug, in adults with nonsense mutation cystic fibrosis (nmCF) in the European Respiratory Journal . The published...

Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD

June 30, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

TOKYO, June 30, 2011 /- GLOW2 Study Shows NVA237 Provides Superior24-hour Bronchodilation to Placebo (p < 0.001) with Comparable Efficacy to Open-Label Tiotropium at 12 Weeks NVA237 Shown to be Well-Tolerated in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease...

Video Features World's First Essential Tremor Patient Treated With Noninvasive MR-Guided Focused Ultrasound

June 29, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

CHARLOTTESVILLE, Va., June 29, 2011 /PRNewswire-USNewswire/ -- The last ten years have been challenging for Billy R. Williams of Fort Valley, Virginia. The former Pentagon employee, who survived the 9/11 terrorist attack, has suffered from essential tremor, a progressive and debilitating...

CardioFocus HeartLightâ„¢ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011

June 29, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

MARLBOROUGH, Mass., June 29, 2011 /- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today  that its technology was featured in a live case and scientific abstract presented at the...

Aeris Therapeutics names new CFO Carter

June 28, 2011 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Aeris Therapeutics LLC, a Woburn-based drug developer focused on treatments for emphysema and other advanced lung diseases, has appointed a new chief financial officer in Charles R. Carter.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading